334 related articles for article (PubMed ID: 22185226)
1. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA
BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226
[TBL] [Abstract][Full Text] [Related]
2. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
[TBL] [Abstract][Full Text] [Related]
3. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
Shang M; Lin L; Cui H
Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis.
Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH
Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378
[TBL] [Abstract][Full Text] [Related]
6. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF
Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721
[TBL] [Abstract][Full Text] [Related]
7. Association of OPG and RANKL gene polymorphisms with bone mineral density in Indian women.
Nair S; Bhadricha H; Patil A; Surve S; Joshi B; Balasinor N; Desai M
Gene; 2022 Oct; 840():146746. PubMed ID: 35868414
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW;
J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
[TBL] [Abstract][Full Text] [Related]
9. Association of
Abdi S; Binbaz RA; Mohammed AK; Ansari MGA; Wani K; Amer OE; Alnaami AM; Aljohani N; Al-Daghri NM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572979
[TBL] [Abstract][Full Text] [Related]
10. Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.
Roshandel D; Holliday KL; Pye SR; Ward KA; Boonen S; Vanderschueren D; Borghs H; Huhtaniemi IT; Adams JE; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; ONeill TW;
Calcif Tissue Int; 2011 Dec; 89(6):446-55. PubMed ID: 21964949
[TBL] [Abstract][Full Text] [Related]
11. Association of Polymorphisms in RANK and RANKL Genes with Osteopenia in Arab Postmenopausal Women.
Abdi S; Bukhari I; Ansari MGA; BinBaz RA; Mohammed AK; Hussain SD; Aljohani N; Al-Daghri NM
Dis Markers; 2020; 2020():1285216. PubMed ID: 33376557
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the influence of the T393C polymorphism of the GNAS gene on the clinical expression of primary hyperparathyroidism.
Piedra M; Berja A; Ramos L; García-Unzueta MT; Morán JM; Ruiz D; Amado JA
Endocrinol Diabetes Nutr; 2017 Dec; 64(10):524-530. PubMed ID: 29179855
[TBL] [Abstract][Full Text] [Related]
14. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of the OPG gene associated with breast cancer.
Ney JT; Juhasz-Boess I; Gruenhage F; Graeber S; Bohle RM; Pfreundschuh M; Solomayer EF; Assmann G
BMC Cancer; 2013 Jan; 13():40. PubMed ID: 23369128
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients.
Yin LL; Jing N; Zhao ZY; Liu XH; Du J; Qin LL; Song JG; Xu Y
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):37-41. PubMed ID: 28121359
[TBL] [Abstract][Full Text] [Related]
17. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
18. Rs219780 SNP of Claudin 14 Gene is not Related to Clinical Expression in Primary Hyperparathyroidism.
Piedra M; Berja A; García-Unzueta MT; Ramos L; Valero C; Amado JA
Clin Lab; 2015; 61(9):1197-203. PubMed ID: 26554238
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.
Eid R; Abdelsalam M; Fathy AA; Abolenein HM; Elmarghany EB; El-Hanafy AA; Hamdy N; Abd-Elmagid DS; Niazy NA; Abd-El Ghaffar DM
Pediatr Rheumatol Online J; 2023 Jun; 21(1):58. PubMed ID: 37328895
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate.
Szymczak J; Bohdanowicz-Pawlak A
Horm Metab Res; 2013 Sep; 45(10):759-64. PubMed ID: 23888411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
